0
Medlab Clinical Limited Banner Image

Medlab Clinical Limited

  • Ticker MDC
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Medlab Clinical Limited Logo Image
  • 51-200 Employees
  • Based in Botany, Australia
Medlab Clinical Limited, a biotechnology company, researches, develops, and commercializes pharmaceutical and nutraceutical products in Australia. Its lead drug candidate includes NanaBis, an oro–buccal administered equimolar tetrahydrocannabinol (THC) and cannabidiol (CBD) formulation as monotherapy, which is in phase 3 multi-centre, quadruple-blind, randomized- withdrawal active, andMore placebo-controlled clinical study for the management of opioid-requiring–bone–pain due to metastatic cancer. The company also develops NanoCelle, a patented sub-micron drug delivery platform that enhances drug solubility issues and enables faster absorption and metabolism of active ingredients. In addition, it offers vitamins and supplements; and virtual clinic services. Medlab Clinical Limited was founded in 2012 and is headquartered in Botany, Australia.
Medlab Clinical Limited

Most Recent Annual Report

Medlab Clinical Limited
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports